A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species

Journal of Infectious Diseases

Volumn 180, Issue 6, 1999, Pages 1939-1949

  Hamouda, Tarek ^a   Hayes, Michael M ^a,c   Cao, Zhengyi ^a   Tonda, Richard ^a   Johnson, Kent ^a   Wright, D Craig ^b   Brisker, Joan ^b   Baker Jr , James R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NOVAVAX INC   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETYLPYRIDINIUM SALT; GLYCEROL OLEATE; POLYSORBATE 60; SOYBEAN OIL; SURFACTANT; TRIBUTYL PHOSPHATE; TRITON X 100;

ARTICLE; BACILLUS ANTHRACIS; BACILLUS CEREUS; BACTERIAL SPORE; BACTERICIDAL ACTIVITY; EMULSION; GERMINATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; BACILLACEAE INFECTIONS; BACILLUS; BACILLUS CEREUS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; EMULSIONS; GLYCERIDES; HUMANS; MICE; MICROSCOPY, ELECTRON; OCTOXYNOL; PHOSPHORIC ACID ESTERS; POLYSORBATES; SOYBEAN OIL; SPORES, BACTERIAL; SURFACE-ACTIVE AGENTS; WOUND INFECTION;

EID: 0032708895     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315124     Document Type: Article

References (27)

1. 1. Dragon DC, Rennie RP. The ecology of anthrax spores: tough but not invincible. Can Vet J 1995; 36:295-301.
2. 2. Welkos SL, Keener TJ, Gibbs PH. Differences in susceptibility of inbred mice to Bacillus anthracis. Infect Immun 1986; 51:795-800.
3. 3. Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA 1997; 278:399-411.
4. 4. Pile JC, Malone JD, Eitzen EM, Friedlander AM. Anthrax as a potential biological weapon. Arch Intern Med 1998; 158:429-34.
5. 5. Ivins B, Fellows P, Pitt L, et al. Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs. Vaccine 1995; 13:1779-84.
6. 6. Mobley JA. Biological warfare in the twentieth century: lessons from the past, challenges for the future. Mil Med 1995; 160:547-53.
7. 7. Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science 1994; 266:1202-8.
8. 8. Jackson PJ, Hugh-Jones ME, Adair DM, et al. PCR analysis of tissue samples from the 1979 Sverdlovsk anthrax victims: the presence of multiple Bacillus anthracis strains in different victims. Proc Natl Acad Sci USA 1998; 95: 1224-9.
9. 9. Drobniewski FA. Bacillus cereus and related species. Clin Microbiol Rev 1993; 6:324-38.
10. 10. Alasri A, Valverde M, Roques C, Michel G. Sporicidal properties of peracetic acid and hydrogen peroxide, alone and in combination, in comparison with chlorine and formaldehyde for ultrafiltration membrane disinfection. Can J Microbiol 1993; 39:52-60.
11. 11. Beauchamp RO Jr, St Clair MB, Fennell TR, Clarke DO, Morgan KT. A critical review of the toxicology of glutaraldehyde. Crit Rev Toxicol 1992; 22:143-74.
12. 12. Hess JA, Molinari JA, Gleason MJ, Radecki C. Epidermal toxicity of dis£ infectants. Am J Dent 1991; 4:51-6.
13. 13. Lineaweaver W, Howard R, Soucy D, et al. Topical antimicrobial toxicity. Arch Surg 1985; 120:267-70.
14. 14. Morgan KT. A brief review of formaldehyde carcinogenesis in relation to rat nasal pathology and human health risk assessment. Toxicol Pathol 1997; 25:291-307.
15. 15. Russell AD. Bacterial spores and chemical sporicidal agents. Clin Microbiol Rev 1990; 3:99-119.
16. 16. Wright DC. Antimicrobial oil-in-water emulsions US patent no. 5,547,677; 1996.
17. 17. Titball RW, Manchee RJ. Factors affecting the germination of spores of Bacillus anthracis. J Appl Bacteriol 1987; 62:269-73.
18. 18. Foster SJ, Johnstone K. Pulling the trigger: the mechanism of bacterial spore germination. Mol Microbiol 1990; 4:137-41.
19. 19. Shibata H, Takamatsu H, Tani I. Germination of inactivated spores of Bacillus cereus T. Effect of preincubation with L-alanine or inosine on the subsequent germination. Jpn J Microbiol 1976; 20:529-35.
20. 4Cl during germination of spores of Bacillus cereus T. J Gen Microbiol 1988; 134:3001-10.
21. 21. Burdon KL, Wende RD. On the differentiation of anthrax bacilli from Bacillus cereus. J Infect Dis 1960; 107:224-34.
22. 22. Burdon KL, Davis JS, Wende RD. Experimental infection of mice with Bacillus cereus: studies of pathogenesis and pathologic changes. J Infect Dis 1967; 117:307-16.
23. 23. Fritz DL, Jaax NK, Lawrence WB, et al. Pathology of experimental anthrax in the rhesus monkey. Lab Invest 1995; 73:691-702.
24. 24. Welkos SL, Friedlander AM. Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis. Microb Pathog 1988; 4:53-69.
25. 25. Lamanna C, Jones L. Lethality for mice of vegetative and spore forms of Bacillus cereus and Bacillus cereus-like insect pathogens injected intraperitoneally and subcutaneously. J Bacteriol 1963; 85:532-5.
26. 26. Cao Z, Tonda R, Morris G, Hamouda T, Johnson K, Baker JR Jr. Sporicidal effect of novel surfactant lipid on B. cereus [abstract C-300]. In: Proceedings of the 99th general meeting of the American Society for Microbiology (Chicago). Washington, DC: ASM, 1999.
27. 27. Chatlyyne LG, Brisker J, Wright DC. A lipid nanoemulsion with effective viricidal activity against HIV-1 and other common viruses [abstract 351]. In: 3rd Conference on Retroviruses and Opportunistic Infections: program and abstracts (Washington, DC). Alexandria, VA: Infectious Diseases Society of America, 1996: 118.